Los puntos clave no están disponibles para este artículo en este momento.
The conservative treatment may be an option for patients with stage IA G2 EEC who desire to preserve their fertility. The immunohistochemical markers evaluation looks promising in predicting response to conservative treatment. Further large series and randomized clinical trials are needed to confirm these results.
Giampaolino et al. (Sat,) studied this question.